The mechanisms that drive cancer cachexia are unclear. Adipocyte activation of GPR81 by high levels of lactate is now shown to drive adipose tissue browning, thermogenesis and a loss of body weight in mouse models of cancer.
References
Ferrer, M. et al. Cell 186, 1824–1845 (2023).
Olson, B., Diba, P., Korzun, T. & Marks, D. L. Cancers 13, 3990 (2021).
Liu, X. et al. Nat. Metab. https://doi.org/10.1038/s42255-024-01011-0 (2024).
Certo, M., Llibre, A., Lee, W. & Mauro, C. Trends Endocrinol. Metab. 33, 722–735 (2022).
Qian, Y. et al. Cancer Cell 41, 1363–1380.e7 (2023).
Petersen, C. et al. Sci. Rep. 7, 13101 (2017).
Hui, S. et al. Nature 551, 115–118 (2017).
Park, G. et al. Nat. Metab. 5, 1204–1220 (2023).
Carrière, A. et al. Diabetes 63, 3253–3265 (2014).
Queiroz, A. L. et al. Nat. Commun. 13, 4633 (2022).
Goncalves, M. D. et al. Proc. Natl Acad. Sci. USA 115, E743–E752 (2018).
Ferrer, M. et al. Cell Metab. 35, 1147–1162.e7 (2023).
Purcell, S. A., Elliott, S. A., Baracos, V. E., Chu, Q. S. C. & Prado, C. M. Eur. J. Clin. Nutr. 70, 1230–1238 (2016).
Li, Z. & Cui, J. Mol. Ther. Oncolytics 31, 100740 (2023).
Chen, S. et al. Biochem. Pharmacol. 217, 115800 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.D.G. reports consulting or advisory roles with Scorpion Therapeutics; stock or other ownership interests in Faeth Therapeutics; honoraria from Novartis AG, Pfizer Inc., and Scorpion Therapeutics; patents, royalties, and other intellectual property with Weill Cornell Medicine. J.D.S declares no competing interests.
Rights and permissions
About this article
Cite this article
Sanford, J.D., Goncalves, M.D. A waste product’s unexpected role in wasting. Nat Metab 6, 608–609 (2024). https://doi.org/10.1038/s42255-024-01010-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s42255-024-01010-1
- Springer Nature Limited